Stock listing

Genexine, Inc.

Selected listing: 095700 · KRX · KRW · KR

Genexine, Inc. (KRX:095700), Health Technology. Latest release Sep 15, 2026: Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib…

095700:KRXKRWKRUpdated October 2, 2026
Genexine, Inc. logo
Ticker
KRX:095700
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
KRX
Currency
KRW

About Genexine, Inc.

Genexine, Inc. is a public company listed on the Korean stock market under the ticker 095700. Genexine focuses on developing innovative biopharmaceutical products.

Latest news from Genexine, Inc.

Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination

September 15, 2026

All Genexine, Inc. news →

Research Genexine, Inc.

Genexine, Inc. company profile

View the public company page for Genexine, Inc. on 6ix.

Genexine, Inc. news

Read company news and market updates connected to Genexine, Inc..

Genexine, Inc. investor events

Find investor webinars, events, and replay context for Genexine, Inc..